Cronos Group Inc. (CRON) Stock

NASDAQ: CRONProduces and sells cannabis products for medical and recreational use globally.

Cronos stock price chart

CRON stock quote & key statistics

Cronos earnings per share

Income →
Earnings per share

Cronos revenue & net income

Income →
RevenueNet income

Cronos annual financials

Income statement →
Cronos Group Inc. revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$149.2M-$9.6M$0.03
FY2024$117.6M$41.1M$0.16
FY2023$87.2M-$74.0M-$0.13
FY2022$86.7M-$168.7M-$0.48
FY2021$64.6M-$396.1M-$0.18

Fiscal year ending December 31. Source: company filings via EODHD.

About Cronos Group Inc.

Cronos Group Inc. is a leading player in the cannabinoid industry, specializing in the manufacture, marketing, and distribution of hemp-derived supplements and cosmetic products across the United States. Through popular brands like Lord Jones and Happy Dance, the company reaches consumers via e-commerce platforms, retail outlets, and hospitality partnerships, catering to a diverse range of wellness needs.

Beyond its consumer product lines, Cronos Group is actively engaged in the cultivation, manufacturing, and marketing of cannabis and cannabis-derived products for both medical and adult-use markets. Under its wellness platform PEACE NATURALS, the company offers a variety of cannabis products including dried cannabis, pre-rolls, edibles, concentrates, and extracts, available through wholesale channels and direct-to-client sales. Emphasizing quality and innovation, Cronos Group also markets adult-use brands such as Spinach, further solidifying its presence in the evolving cannabis market.

Founded in 2012 and headquartered in Toronto, Canada, Cronos Group has expanded its global footprint by exporting dried cannabis and cannabis oils to key international markets including Germany, Israel, and Australia. With a commitment to advancing cannabinoid-based therapies and products, Cronos Group continues to shape the future of cannabis through strategic growth initiatives and ongoing research and development efforts.

Cronos stock FAQ

What is the Cronos stock ticker symbol?

Cronos Group Inc. trades on the NASDAQ under the ticker symbol CRON.

What sector and industry is Cronos in?

Cronos Group Inc. is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

How many employees does Cronos have?

Cronos Group Inc. has about 610 full-time employees.

What were Cronos's revenue and earnings last fiscal year?

Cronos reported revenue of $149.2M and net income of -$9.6M in fiscal 2025, with earnings per share of $0.03. Revenue grew 26.8% from the prior year.

When did Cronos go public?

Cronos stock began trading on July 12, 2016.

Drug Manufacturers - Specialty & Generic stocks

All Healthcare stocks →